Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheet (Parenthetical)

v3.7.0.1
Consolidated Balance Sheet (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2017
Dec. 31, 2016
Assets    
Federal funds sold and securities borrowed or purchased under agreements to resell measured at fair value $ 58,545 $ 49,750
Trading account assets, pledged as collateral 119,058 106,057
Debt securities:    
Carried at fair value, pledged as collateral 27,870 29,804
Held-to-maturity, fair value 114,003 115,285
Held-to-maturity, pledged as collateral 8,244 8,233
Loans and leases, measured at fair value 7,528 7,085
Loans and leases, pledged as collateral 47,410 31,805
Loans held-for-sale, measured at fair value 3,745 4,026
Customer and other receivables, measured at fair value 250  
Assets of business held-for-sale at fair value 691 619
Other assets, measured at fair value 14,639 13,802
Deposits in U.S. offices:    
Interest-bearing, measured at fair value 598 731
Federal funds purchased and securities loaned or sold under agreements to repurchase, measured at fair value 36,663 35,766
Short-term borrowings, measured at fair value 1,041 2,024
Accrued expenses and other liabilities, measured at fair value 16,245 14,630
Accrued expenses and other liabilities, reserve for unfunded lending commitments 757 762
Long-term debt, measured at fair value $ 29,617 $ 30,037
Shareholders’ equity    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock authorized (in shares) 100,000,000 100,000,000
Preferred stock issued (in shares) 3,887,329 3,887,329
Preferred stock outstanding (in shares) 3,887,329 3,887,329
Common stock par value (in dollars per share) $ 0.01 $ 0.01
Common stock authorized (in shares) 12,800,000,000 12,800,000,000
Common stock issued (in shares) 9,974,189,863 10,052,625,604
Common stock outstanding (in shares) 9,974,189,863 10,052,625,604
Consolidated VIEs | Long-term debt    
Shareholders’ equity    
Non-recourse debt $ 11,730 $ 10,417
Consolidated VIEs | Other liabilities    
Shareholders’ equity    
Non-recourse debt $ 34 $ 38